TopTier Wealth Management’s Biogen BIIB Stock Holding History

TopTier Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-336	Closed	-$61.6K	–	191
2026 Q1	$61.6K	Buy	+336	New	+$61.9K	0.04%	206

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TopTier Wealth Management's BIIB Position: Q2 2026 in Review

TopTier Wealth Management sold out of Biogen (BIIB) in Q2 2026, closing a stake of 336 shares — an estimated $61.6K sold.

TopTier Wealth Management first reported a position in BIIB in Q1 2026 and held it in 1 quarter. The position peaked at $61.6K in Q1 2026. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

TopTier Wealth Management reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
TopTier Wealth Management sold 336 Biogen shares in Q2 2026, an estimated $61.6K.
TopTier Wealth Management first reported a position in Biogen in Q1 2026 and held it in 1 quarter.
TopTier Wealth Management's Biogen position peaked at $61.6K in Q1 2026.
1,041 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on TopTier Wealth Management's 13F filing for Q2 2026, filed 14 Jul 2026.